Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 191

1.

Metals in medicine.

Nash RA.

Altern Ther Health Med. 2005 Jul-Aug;11(4):18-25. Review.

PMID:
16053118
2.

Chelation for heavy metals (arsenic, lead, and mercury): protective or perilous?

Kosnett MJ.

Clin Pharmacol Ther. 2010 Sep;88(3):412-5. doi: 10.1038/clpt.2010.132. Epub 2010 Jul 21.

PMID:
20664538
3.

Medical toxicology case presentations: to chelate or not to chelate, is that the question?

McKay CA Jr.

J Med Toxicol. 2013 Dec;9(4):373-9. doi: 10.1007/s13181-013-0338-3.

4.

EDTA chelation reappraisal following new clinical trials and regular use in millions of patients: review of preliminary findings and risk/benefit assessment.

Born T, Kontoghiorghe CN, Spyrou A, Kolnagou A, Kontoghiorghes GJ.

Toxicol Mech Methods. 2013 Jan;23(1):11-7. doi: 10.3109/15376516.2012.730562. Epub 2012 Oct 19.

PMID:
22991933
5.

Environmental evaluation of a child with developmental disability.

Hussain J, Woolf AD, Sandel M, Shannon MW.

Pediatr Clin North Am. 2007 Feb;54(1):47-62, viii. Review.

PMID:
17306683
6.
7.
8.

Chelation: harnessing and enhancing heavy metal detoxification--a review.

Sears ME.

ScientificWorldJournal. 2013 Apr 18;2013:219840. doi: 10.1155/2013/219840. Print 2013. Review.

9.

Heavy metal chelation in neurotoxic exposures.

Jang DH, Hoffman RS.

Neurol Clin. 2011 Aug;29(3):607-22. doi: 10.1016/j.ncl.2011.05.002. Epub 2011 Jul 2. Review.

PMID:
21803213
10.

Arsenic and lead induced free radical generation and their reversibility following chelation.

Flora SJ, Flora G, Saxena G, Mishra M.

Cell Mol Biol (Noisy-le-grand). 2007 Apr 15;53(1):26-47. Review.

PMID:
17519110
11.

Introduction to special issue: use and misuse of metal chelation therapy.

McKay CA Jr.

J Med Toxicol. 2013 Dec;9(4):298-300. doi: 10.1007/s13181-013-0346-3. No abstract available.

12.

Chelators as antidotes of metal toxicity: therapeutic and experimental aspects.

Blanusa M, Varnai VM, Piasek M, Kostial K.

Curr Med Chem. 2005;12(23):2771-94. Review.

PMID:
16305472
13.

Chronic Toxic Metal Exposure and Cardiovascular Disease: Mechanisms of Risk and Emerging Role of Chelation Therapy.

Aneni EC, Escolar E, Lamas GA.

Curr Atheroscler Rep. 2016 Dec;18(12):81. Review.

PMID:
27822681
14.

Deaths associated with hypocalcemia from chelation therapy--Texas, Pennsylvania, and Oregon, 2003-2005.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2006 Mar 3;55(8):204-7.

15.

EDTA chelation therapy in the treatment of vascular disease.

Chappell LT, Janson M.

J Cardiovasc Nurs. 1996 Apr;10(3):78-86. Review.

PMID:
8820322
16.

Metal chelation therapy in rheumathoid arthritis: a case report. Successful management of rheumathoid arthritis by metal chelation therapy.

Bamonti F, Fulgenzi A, Novembrino C, Ferrero ME.

Biometals. 2011 Dec;24(6):1093-8. doi: 10.1007/s10534-011-9467-9. Epub 2011 Jun 8.

PMID:
21655943
18.
19.

Heavy metal toxicity, Part I: arsenic and mercury.

Graeme KA, Pollack CV Jr.

J Emerg Med. 1998 Jan-Feb;16(1):45-56. Review.

PMID:
9472760
20.

Current use of chelation in American health care.

Wax PM.

J Med Toxicol. 2013 Dec;9(4):303-7. doi: 10.1007/s13181-013-0347-2. Review.

Supplemental Content

Support Center